Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
BD0801 (APX003)
print preview
bookmark
share with colleague
General Information
Company
Apexigen Inc.
Description
Humanized mAb directed against VEGF
Molecular Target
Vascular endothelial growth factor (VEGF)
Mechanism of Action
Latest Stage of Development
Phase I
Indication
Cancer
Partner
Simcere Pharmaceutical Group
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy